2016 年中国与世界创新与发展论坛

市场篇 2016 年 6 月 21 日
Session on Market  21 June,2016

谈圣采先生，中国医药保健品进出口商会秘书长
Mr. Tan Shengcai, Secretary General of China Chamber of Commerce for Import and Export of Medicines and Health Products 

中国医药工业发展规划（2016-2020 年）解读
Policy Analysis on the 13th Five-Year Plan to promote the Healthcare Industry in China

工业和信息化部
Ministry of Industry and Information Technology

非洲医药市场战略及行动计划(待定)
（TBC）Market Strategy and Action Plan in accessing African Pharmaceutical Market

中国医药保健品进出口商会对外合作部
International Cooperation Department of China Chamber of Commerce for Import and Export of Medicines and Health Products 

俄罗斯医药行业发展战略
Development Strategy for Russia Pharmaceutical Industry 

俄罗斯工业和贸易部
Ministry of Industry and Trade of the Russian Federation

中澳自贸协定政策解读
Policy Analysis on the FTA between China and Australi

 澳大利亚使馆商务处
Trade Section of Australian Embassy to China

法规篇 2016 年 6 月 22 日
Session on Regulations  22 June,2016

法规监管下的实验室分析测试面临的挑战
Challenges in Regulated Laboratory Testing

天祥集团
Intertek Life Sciences

欧盟医药市场准入概况–-未来变化带来的机遇与障碍 (待定)
（TBC）The European Pharma Market – an overview on Hurdles and Opportunities of upcoming changes

德国 Diapharm GmbH 公司
Diapharm GmbH & Co. KG

国际医药市场知识产权战略 (待定)
（TBC）IP Strategy in the International Pharmaceutical Market

冉瑞雪女士，科文顿•柏灵律师事务所合伙人
Mrs. Ran Ruixue, Covington & Burling LLP

（TBC）Benefits when Being listed in the Singapore Exchange Market

新交所
Singapore Exchange Limited